A CASE OF 10P- SYNDROMESUCIU S; NANULESCU M.1983; ANNALES DE GENETIQUE; ISSN 0003-3995; FRA; DA. 1983; VOL. 26; NO 2; PP. 109-111; ABS. FRE; BIBL. 11 REF.Article

DOUBLE ATRIAL PARASYSTOLE. CASE REPORT.COTOI S; SUCIU S.1976; ACTA CARDIOL.; BELG.; DA. 1976; VOL. 31; NO 3; PP. 255-259; ABS. FR. ESP.; BIBL. 10 REF.Article

The value of BMT in AML patients in first remission : a statistician's view-pointSUCIU, S.Annals of hematology (Print). 1991, Vol 62, Num 2-3, pp 41-44, issn 0939-5555, 4 p.Article

Constitutive heterochromatin studies in patients with solid tumorsSUCIU, S.Journal of cancer research and clinical oncology. 1986, Vol 111, Num 3, pp 291-294, issn 0171-5216Article

Occurence of 19p- in an infant with multiple dysmorphic featuresHURGOIU, V; SUCIU, S.Annales de génétique (Paris). 1984, Vol 27, Num 1, pp 56-57, issn 0003-3995Article

Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factorsOOSTERVELD, M; MUUS, P; WILLEMZE, R et al.Leukemia. 2002, Vol 16, Num 9, pp 1615-1621, issn 0887-6924Article

The Children Leukemia Group: 30 years of research and achievementsOTTEN, J; PHILIPPE, N; SUCIU, S et al.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 4, pp S44-S49, issn 1359-6349Article

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy : A cross-sectional study of the EORTC-GIMENA AML 8A trialZITTOUN, R; SUCIU, S; DARDENNE, M et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 4, pp 307-315, issn 0268-3369Article

Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin : A phase-II study (no. 06901) of the EORTC Leukemia Cooperative GroupDE WITTE, T; SUCIU, S; SOLBU, G et al.Annals of hematology (Print). 1996, Vol 72, Num 3, pp 119-124, issn 0939-5555Article

Immunophenotype of mitotic cells with clonal chromosome abnormalities demonstrating multilineage involvement in acute myeloid leukemiaSUCIU, S; ZELLER, W; WEH, H. J et al.Cancer genetics and cytogenetics. 1993, Vol 70, Num 1, pp 1-5, issn 0165-4608Article

Prognostic significance of chromosome analysis in de novo acute myeloid leukemiaWEH, H. J; HOFFMANN, R; SUCIU, S et al.Haematology and blood transfusion. 1990, Vol 33, pp 150-152, issn 0171-7111Article

Pentostatin (2'-deoxycoformycin) for the treatment of lymphoid neoplasmsHO, A. D; THALER, J; SUCIU, S et al.Cancer treatment reviews. 1990, Vol 17, Num 2-3, pp 213-215, issn 0305-7372, 3 p.Article

Pentostatin in refractory chronic lymphocytic leukemia : a phase II trial of the european organization for research and treatment of cancerHO, A. D; THALER, J; DE WITTE, T et al.Journal of the National Cancer Institute. 1990, Vol 82, Num 17, pp 1416-1420, issn 0027-8874Article

An assessment of DTIC versus levamisole or placebo in the treatment of high risk stage I patients after surgical removal of a primary melanoma of the skin. A phase III adjuvant study. EORTC protocol 18761LEJEUNE, F. J; MACHER, E; KLEEBERG, U et al.European journal of cancer & clinical oncology. 1988, Vol 24, pp 81-90, issn 0277-5379, suppl. 2Article

Prognostic value of cytologic parameters acute myelogenous leukemia = Valeur pronostique des paramètres cytologiques de la leucémie myélocytaire aiguëZITTOUN, R; CADIOU, M; BAYLE, C et al.Cancer. 1984, Vol 53, Num 7, pp 1526-1532, issn 0008-543XArticle

Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanomaKIVELÄ, T; SUCIU, S; HUMBLET, Y et al.European journal of cancer (1990). 2003, Vol 39, Num 8, pp 1115-1120, issn 0959-8049, 6 p.Article

The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)OOSTERVELD, M; SUCIU, S; AMADORI, S et al.Leukemia. 2003, Vol 17, Num 5, pp 859-868, issn 0887-6924, 10 p.Article

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia : a CLCG-EORTC reportVILMER, E; SUCIU, S; MANEL, A.-M et al.Leukemia. 2000, Vol 14, Num 12, pp 2257-2266, issn 0887-6924Article

Pentostatin (nipent) in T-cell malignanciesHO, A. D; SUCIU, S; ZITTOUN, R et al.Seminars in oncology. 2000, Vol 27, Num 2, pp 52-57, issn 0093-7754, SUP5Conference Paper

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemiaCAVE, H; VAN DER WERFF TEN BOSCH, J; SUCIU, S et al.The New England journal of medicine. 1998, Vol 339, Num 9, pp 591-598, issn 0028-4793Article

Prophylactic isolated limb perfusion for localized, high-risk limb melanoma : Results of a multicenter randomized phase III trialKOOPS, H. S; VAGLINI, M; LEJEUNE, F. J et al.Journal of clinical oncology. 1998, Vol 16, Num 9, pp 2906-2912, issn 0732-183XArticle

Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML) : Final report of AML-11, a phase III randomized study of the leukemia cooperative group of European organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian hemato-oncology cooperative group (HOVON)LÖWENBERG, B; SUCIU, S; SCHOUTEN, H et al.Blood. 1997, Vol 90, Num 8, pp 2952-2961, issn 0006-4971Article

A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia : an EORTC Leukemia Cooperative Group phase II study (06893)WILLEMZE, R; SUCIU, S; JEHN, U et al.Leukemia. 1997, Vol 11, pp S24-S27, issn 0887-6924, SUP1Conference Paper

How to study therapy dilemmas with respect to BMT ?HERMANS, J; LABOPIN, M; SUCIU, S et al.Bone marrow transplantation. Supplement (Basingstoke). 1993, Vol 12, Num 4, pp S107-S108, issn 0951-3078Conference Paper

Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemias (AML) in first remission. An EORTC/Gimema phase III trial (AML8 B)ZITTOUN, R; LISO, V; SOLBU, G et al.Leukemia. 1992, Vol 6, pp 76-77, issn 0887-6924, SUP2Conference Paper